NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

For patients with asthma aged 6 years and older, which anticholinergic is approved for use?

Ipratropium
Aclidinium
Tiotropium (Spiriva Respimat)
Oxitropium

The correct answer is: Tiotropium (Spiriva Respimat)

For patients with asthma aged 6 years and older, tiotropium (Spiriva Respimat) is the approved anticholinergic. This medication is a long-acting muscarinic antagonist (LAMA) that helps relax the airway muscles and reduce bronchoconstriction, making it beneficial in the management of asthma symptoms. Ipratropium (Choice A) is also an anticholinergic medication often used for the treatment of asthma and chronic obstructive pulmonary disease (COPD), but it is typically more commonly used in the form of a short-acting bronchodilator rather than for regular asthma maintenance. Aclidinium (Choice B) is another anticholinergic medication approved for the treatment of COPD but is not typically used for asthma management. Oxitropium (Choice D) is not a commonly used anticholinergic medication for asthma and is not among the approved options for patients with asthma aged 6 years and older.